CING News and Press, Cingulate Inc. From 02/27/23

3 Tips for Building a Long Term Penny Stock Portfolio Building a penny stocks portfolio can be a smart strategy for investors who are willing to take on a higher level of risk in exchange for the potential for higher returns. While penny stocks can be volatile and risky, they can also off...

3 Tips for Not Letting Emotions Get in the Way of Making Money With Penny Stocks When it comes to penny stock trading, managing your emotions can be just as important as having a solid trading strategy. Penny stocks are often associated with high risk and high reward, which can make them ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Nektar Therapeutics (NASDAQ: NKTR ) stock is taking a beating on Friday following the release of Phase 2 clinical trial data . This Phase 2 study had Nektar Therapeutics te...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: aslysun / Shutterstock.com SELLAS Life Sciences (NASDAQ: SLS ) stock is falling on Friday after the late-stage clinical biopharmaceutical company announced a proposed public offering . According to a pres...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Bridger Aerospace (NASDAQ: BAER ) stock is taking off on Friday after a filing revealed stakes in the company . According to the U.S. Securities and Exchange Commission (SEC) filing, JCIC Spo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Cingulate (NASDAQ: CING ) stock is on the rise Friday after releasing positive data concerning its ADHD treatment . The big news today is Cingulate’s CTx-1301 can be taken with or with...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on! Moving stocks this morning are earnings reports, clinica...

Cingulate ( NASDAQ: CING ) on Thursday reported what it deemed to be positive results from a study assessing its tablet formulation of dexmethylphenidate. Shares of the biopharmaceutical company soared more than 75% to $1.92 after hours. Dexmethylphenidate is a compound approv...

Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food CTx-1301 is Designed as a True, Entire Active-Day Treatment for ADHD KANSAS CITY, Kan., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical company utilizing its ...

Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in San Francisco KANSAS CITY, Kan., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical co...